bis[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl] dodecanedioate | 1396742-23-6

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: bis[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl] dodecanedioate
• CAS: 1396742-23-6
• 化学式: C₃₂H₄₄N₁₀O₁₀
• 分子量: 728.762
• InChiKey: FDWJEINFFHQCPE-XOGRSFEHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  52
• 可旋转键数：
  21
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.69
• 拓扑面积：
  199
• 氢给体数：
  2
• 氢受体数：
  14

反应信息

• 作为产物：
  描述：

  十二烷二酸 、 齐多夫定 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以30%的产率得到bis[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl] dodecanedioate
  参考文献：
  名称：

  双核苷逆转录酶抑制剂的对称二羧酸酯的合成及其抗HIV活性

  摘要：

  三种核苷类似物3'-氟-2'，3'-二脱氧胸苷（FLT），3'-叠氮基2'，3'-二脱氧胸苷（AZT）和2'，3'-二脱氧胸苷3'-硫代胞苷（将3TC）与三种不同的二羧酸缀合以提供核苷的长链二羧酸酯。通常，FLT和3TC与长链二元羧酸的二核苷酯共轭物显示出比其母体核苷更高的抗HIV活性。发现FLT的十二烷酸酯和十四烷酸酯二核苷酯衍生物是针对HIV-1 US / 92/727和HIV-1 IIIB细胞的EC 50值分别为0.8-1.0 nM和3-4 nM的最有效化合物。含有长链二羧酸二酯的3TC偶联物的抗HIV活性（EC 50 = 3-60 nM）与3TC（EC 50  = 90-200 nM）相比提高了1.5-66倍。这项研究表明，二羧酸与许多核苷的对称酯缀合可产生具有改进的抗HIV谱的缀合物。

  DOI：

  10.1016/j.bmcl.2012.07.037

文献信息

• Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine
  作者：Hilda A. Namanja-Magliano、Kelsey Bohn、Neha Agrawal、Meghan E. Willoughby、Christine A. Hrycyna、Jean Chmielewski

  DOI：10.1016/j.bmc.2017.07.001

  日期：2017.10

  The brain provides a sanctuary site for HIV due, in part, to poor penetration of antiretroviral agents at the blood-brain barrier. This lack of penetration is partially attributed to drug efflux transporters such as P-glycoprotein (P-gp) and ABCG2. Inhibition of both ABCG2 and P-gp is critical for enhancing drug accumulation into the brain. In this work, we have developed a class of homodimers based on the HIV reverse transcriptase inhibitor azidothymidine (AZT) that effectively inhibits P-gp and ABCG2. These agents block transporter mediated efflux of the P-gp substrate calcein-AM and the ABCG2 substrate mitoxantrone. The homodimers function by interacting with the transporter drug binding sites as demonstrated by competition studies with the photo-affinity agent and P-gp/ABCG2 substrate [I-125]iodoarylazidoprazosin. As such, these dual inhibitors of both efflux transporters provide a model for the future development of delivery vehicles for antiretroviral agents to the brain. (C) 2017 Elsevier Ltd. All rights reserved.